NHS (Neuberger High Yield Strategies Fund Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by NHS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | BANK OF AMERICA NA | 10%+ Owner | J | — | — |
| 2026-04-27 | Chris Kocinski | — | X | — | — |
| 2026-04-24 | Joseph Lind | — | X | — | — |
| 2025-07-21 | Chris Kocinski | — | Buy | — | — |
| 2025-05-30 | Chris Kocinski | — | Buy | — | — |
| 2023-09-20 | MetLife Investment Management, LLC | 10%+ Owner | J | — | — |
| 2023-07-05 | Joseph Lind | — | X | — | — |
| 2023-07-05 | BRADLEY TANK | — | X | — | — |
| 2023-06-23 | GEORGE W MORRISS | Director | X | — | — |
| 2023-06-23 | Joseph Lind | — | X | — | — |
| 2023-06-23 | BRADLEY TANK | — | X | — | — |
| 2022-06-10 | MetLife Investment Management, LLC | 10%+ Owner | MIXED | — | — |
| 2022-06-10 | MetLife Investment Management, LLC | 10%+ Owner | J | — | — |
| 2022-06-08 | Joseph Lind | — | Buy | — | — |
| 2022-06-07 | MetLife Investment Management, LLC | 10%+ Owner | Buy | — | — |
| 2022-05-19 | BRADLEY TANK | — | X | — | — |
| 2022-05-19 | GEORGE W MORRISS | Director | X | — | — |
| 2022-05-19 | Joseph Lind | — | X | — | — |
| 2020-12-16 | Saba Capital Management, L.P. | 10%+ Owner | D | — | — |
| 2020-12-14 | Saba Capital Management, L.P. | 10%+ Owner | Sell | — | — |
| 2020-05-28 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-05-26 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-05-21 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-05-19 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-05-15 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-05-13 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-05-11 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-05-07 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-05-05 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-04-29 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-04-20 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-04-16 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-04-06 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-04-02 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-03-31 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-03-27 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-03-25 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-03-23 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-03-18 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-03-16 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-03-11 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2020-03-06 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2020-03-04 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2019-04-12 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2019-04-10 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2019-04-08 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2019-04-03 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2019-04-01 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| 2019-03-28 | Saba Capital Management, L.P. | 10%+ Owner | Buy | — | — |
| 2019-03-25 | Boaz Weinstein | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 4,874,870 | — |
| — | 10%+ Owner | 1,202,787 | — |
| — | — | 340,855 | — |
| — | — | 45,333 | — |
| — | Portfolio Manager | 38,244 | — |
| — | — | 28,000 | — |
| — | — | 24,695 | — |
| — | — | 18,553 | — |
| — | Director | 13,689 | — |
| — | 10%+ Owner | 500 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NHS quote page; the site-wide leaderboard is on the insider transactions hub.